p53-dependent elimination of aneuploid mitotic offspring by entosis.


Journal

Cell death and differentiation
ISSN: 1476-5403
Titre abrégé: Cell Death Differ
Pays: England
ID NLM: 9437445

Informations de publication

Date de publication:
02 2021
Historique:
received: 22 04 2020
accepted: 12 10 2020
pubmed: 29 10 2020
medline: 16 12 2021
entrez: 28 10 2020
Statut: ppublish

Résumé

Entosis was proposed to promote aneuploidy and genome instability by cell-in-cell mediated engulfment in tumor cells. We reported here, in epithelial cells, that entosis coupled with mitotic arrest functions to counteract genome instability by targeting aneuploid mitotic progenies for engulfment and elimination. We found that the formation of cell-in-cell structures associated with prolonged mitosis, which was sufficient to induce entosis. This process was controlled by the tumor suppressor p53 (wild-type) that upregulates Rnd3 expression in response to DNA damages associated with prolonged metaphase. Rnd3-compartmentalized RhoA activities accumulated during prolonged metaphase to drive cell-in-cell formation. Remarkably, this prolonged mitosis-induced entosis selectively targets non-diploid progenies for internalization, blockade of which increased aneuploidy. Thus, our work uncovered a heretofore unrecognized mechanism of mitotic surveillance for entosis, which eliminates newly born abnormal daughter cells in a p53-dependent way, implicating in the maintenance of genome integrity.

Identifiants

pubmed: 33110215
doi: 10.1038/s41418-020-00645-3
pii: 10.1038/s41418-020-00645-3
pmc: PMC7862607
doi:

Substances chimiques

TP53 protein, human 0
Tumor Suppressor Protein p53 0
RHOA protein, human 124671-05-2
rhoA GTP-Binding Protein EC 3.6.5.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

799-813

Références

Sivakumar S, Gorbsky GJ. Spatiotemporal regulation of the anaphase-promoting complex in mitosis. Nat Rev Mol Cell Biol. 2015;16:82–94.
pubmed: 25604195 pmcid: 4386896 doi: 10.1038/nrm3934
Musacchio A. The molecular biology of spindle assembly checkpoint signaling dynamics. Curr Biol. 2015;25:R1002–18.
pubmed: 26485365 doi: 10.1016/j.cub.2015.08.051
Kapanidou M, Curtis NL, Bolanos-Garcia VM. Cdc20: at the crossroads between chromosome segregation and mitotic exit. Trends Biochem Sci. 2017;42:193–205.
pubmed: 28202332 doi: 10.1016/j.tibs.2016.12.001
Gao YF, Li T, Chang Y, Wang YB, Zhang WN, Li WH, et al. Cdk1-phosphorylated CUEDC2 promotes spindle checkpoint inactivation and chromosomal instability. Nat Cell Biol. 2011;13:924–33.
pubmed: 21743465 doi: 10.1038/ncb2287
Vitale I, Galluzzi L, Castedo M, Kroemer G. Mitotic catastrophe: a mechanism for avoiding genomic instability. Nat Rev Mol Cell Biol. 2011;12:385–92.
pubmed: 21527953 doi: 10.1038/nrm3115
Santaguida S, Amon A. Short- and long-term effects of chromosome mis-segregation and aneuploidy. Nat Rev Mol Cell Biol. 2015;16:473–85.
pubmed: 26204159 doi: 10.1038/nrm4025
Funk LC, Zasadil LM, Weaver BA. Living in CIN: mitotic infidelity and its consequences for tumor promotion and suppression. Dev Cell. 2016;39:638–52.
pubmed: 27997823 pmcid: 5204306 doi: 10.1016/j.devcel.2016.10.023
Overholtzer M, Mailleux AA, Mouneimne G, Normand G, Schnitt SJ, King RW, et al. A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion. Cell. 2007;131:966–79.
pubmed: 18045538 doi: 10.1016/j.cell.2007.10.040
Sun Q, Cibas ES, Huang H, Hodgson L, Overholtzer M. Induction of entosis by epithelial cadherin expression. Cell Res. 2014;24:1288–98.
pubmed: 25342558 pmcid: 4220160 doi: 10.1038/cr.2014.137
Wang M, Niu Z, Qin H, Ruan B, Zheng Y, Ning X, et al. Mechanical ring interfaces between adherens junction and contractile actomyosin to coordinate entotic cell-in-cell formation. Cell Rep. 2020;32:108071.
pubmed: 32846129 doi: 10.1016/j.celrep.2020.108071
Liang J, Fan J, Wang M, Niu Z, Zhang Z, Yuan L, et al. CDKN2A inhibits formation of homotypic cell-in-cell structures. Oncogenesis. 2018;7:1–8.
doi: 10.1038/s41389-017-0016-4
Wang C, Chen A, Ruan B, Niu Z, Su Y, Qin H, et al. PCDH7 inhibits the formation of homotypic cell-in-cell structure. Front Cell Dev Biol. 2020;8:1–12.
doi: 10.3389/fcell.2020.00001
Ruan B, Wang C, Chen A, Liang J, Niu Z, Zheng Y, et al. Expression profiling identified IL-8 as a regulator of homotypic cell-in-cell formation. BMB Rep. 2018;51:412–7.
pubmed: 30021676 pmcid: 6130832 doi: 10.5483/BMBRep.2018.51.8.089
Ruan B, Zhang B, Chen A, Yuan L, Liang J, Wang M, et al. Cholesterol inhibits entotic cell-in-cell formation and actomyosin contraction. Biochem Biophys Res Commun. 2018;495:1440–6.
pubmed: 29198709 doi: 10.1016/j.bbrc.2017.11.197
Florey O, Kim SE, Sandoval CP, Haynes CM, Overholtzer M. Autophagy machinery mediates macroendocytic processing and entotic cell death by targeting single membranes. Nat Cell Biol. 2011;13:1335–43.
pubmed: 22002674 pmcid: 3223412 doi: 10.1038/ncb2363
Sun Q, Luo T, Ren Y, Florey O, Shirasawa S, Sasazuki T, et al. Competition between human cells by entosis. Cell Res. 2014;24:1299–310.
pubmed: 25342560 pmcid: 4220161 doi: 10.1038/cr.2014.138
Kroemer G, Perfettini J-L. Entosis, a key player in cancer cell competition. Cell Res. 2014;24:1280–1.
pubmed: 25342563 pmcid: 4220158 doi: 10.1038/cr.2014.133
Krajcovic M, Johnson NB, Sun Q, Normand G, Hoover N, Yao E, et al. A non-genetic route to aneuploidy in human cancers. Nat Cell Biol. 2011;13:324–30.
pubmed: 21336303 pmcid: 3576821 doi: 10.1038/ncb2174
Mackay HL, Moore D, Hall C, Birkbak NJ, Jamal-Hanjani M, Karim SA, et al. Genomic instability in mutant p53 cancer cells upon entotic engulfment. Nat Commun. 2018;9:3070.
pubmed: 30076358 pmcid: 6076230 doi: 10.1038/s41467-018-05368-1
Bieging KT, Mello SS, Attardi LD. Unravelling mechanisms of p53-mediated tumour suppression. Nat Rev Cancer. 2014;14:359–70.
pubmed: 24739573 pmcid: 4049238 doi: 10.1038/nrc3711
Joerger AC, Fersht AR. The p53 pathway: origins, inactivation in cancer, and emerging therapeutic approaches. Annu Rev Biochem. 2016;85:375–404.
pubmed: 27145840 doi: 10.1146/annurev-biochem-060815-014710
Kruiswijk F, Labuschagne CF, Vousden KH. p53 in survival, death and metabolic health: a lifeguard with a licence to kill. Nat Rev Mol Cell Biol. 2015;16:393–405.
pubmed: 26122615 doi: 10.1038/nrm4007
Ranjan A, Iwakuma T. Non-canonical cell death induced by p53. Int J Mol Sci. 2016;17:2068.
pmcid: 5187868 doi: 10.3390/ijms17122068
Sun Q, Overholtzer M. Methods for the study of entosis. In: McCall K, Klein C, editors. Methods in Mol Biol-Necrosis, Vol. 1004. Totowa, NJ: Humana Press; 2013, pp 59–66.
Pertz O, Hodgson L, Klemke RL, Hahn KM. Spatiotemporal dynamics of RhoA activity in migrating cells. Nature. 2006;440:1069–72.
pubmed: 16547516 doi: 10.1038/nature04665
Durgan J, Tseng YY, Hamann JC, Domart MC, Collinson L, Hall A, et al. Mitosis can drive cell cannibalism through entosis. eLife. 2017;6:1–26.
doi: 10.7554/eLife.27134
Ganem NJ, Pellman D. Linking abnormal mitosis to the acquisition of DNA damage. J Cell Biol. 2012;199:871–81.
pubmed: 23229895 pmcid: 3518222 doi: 10.1083/jcb.201210040
Ning X, Luo T, Chen Z, Sun Q. The physics for the formation of cell-in-cell structures. Curr Mol Med. 2015;15:867–72.
pubmed: 26511704 doi: 10.2174/1566524015666151026105123
Xia M, Land H. Tumor suppressor p53 restricts Ras stimulation of RhoA and cancer cell motility. Nat Struct Mol Biol. 2007;14:215–23.
pubmed: 17310253 doi: 10.1038/nsmb1208
Gadea G, de Toledo M, Anguille C, Roux P. Loss of p53 promotes RhoA-ROCK-dependent cell migration and invasion in 3D matrices. J CeLL Biol. 2007;178:23–30.
pubmed: 17606864 pmcid: 2064414 doi: 10.1083/jcb.200701120
Ongusaha PP, Kim HG, Boswell SA, Ridley AJ, Der CJ, Dotto GP, et al. RhoE is a pro-survival p53 target gene that inhibits ROCK I-mediated apoptosis in response to genotoxic stress. Curr Biol. 2006;16:2466–72.
pubmed: 17174923 pmcid: 2779528 doi: 10.1016/j.cub.2006.10.056
Zhu Y, Zhou J, Xia H, Chen X, Qiu M, Huang J, et al. The Rho GTPase RhoE is a p53-regulated candidate tumor suppressor in cancer cells. Int J Oncol. 2014;44:896–904.
pubmed: 24399089 doi: 10.3892/ijo.2014.2245
Riento K, Guasch RM, Garg R, Jin B, Ridley AJ. RhoE binds to ROCK I and inhibits downstream signaling. Mol Cell Biol. 2003;23:4219–29.
pubmed: 12773565 pmcid: 156133 doi: 10.1128/MCB.23.12.4219-4229.2003
Wennerberg K, Forget M-A, Ellerbroek SM, Arthur WT, Burridge K, Settleman J, et al. Rnd proteins function as RhoA antagonists by activating p190 RhoGAP. Curr Biol. 2003;13:1106–15.
pubmed: 12842009 pmcid: 6918695 doi: 10.1016/S0960-9822(03)00418-4
Dalton WB, Nandan MO, Moore RT, Yang VW. Human cancer cells commonly acquire dna damage during mitotic arrest. Cancer Res. 2007;67:11487–92.
pubmed: 18089775 doi: 10.1158/0008-5472.CAN-07-5162
Bakhoum SF, Kabeche L, Murnane JP, Zaki BI, Compton DA. DNA-damage response during mitosis induces whole-chromosome missegregation. Cancer Discov. 2014;4:1281–9.
pubmed: 25107667 pmcid: 4221427 doi: 10.1158/2159-8290.CD-14-0403
Bakhoum SF, Kabeche L, Compton DA, Powell SN, Bastians H. Mitotic DNA damage response: at the crossroads of structural and numerical cancer chromosome instabilities. Trends Cancer. 2017;3:225–34.
pubmed: 28718433 pmcid: 5518619 doi: 10.1016/j.trecan.2017.02.001
Heijink AM, Krajewska M, van Vugt MA. The DNA damage response during mitosis. Mutat Res. 2013;750:45–55.
pubmed: 23880065 doi: 10.1016/j.mrfmmm.2013.07.003
Orthwein A, Fradet-Turcotte A, Noordermeer SM, Canny MD, Brun CM, Strecker J, et al. Mitosis inhibits DNA double-strand break repair to guard against telomere fusions. Science. 2014;344:189–93.
pubmed: 24652939 doi: 10.1126/science.1248024
Denchi EL, Li J. Let it go: how to deal with a breakup in mitosis. Nat Struct Mol Biol. 2014;21:433–5.
pubmed: 24799037 doi: 10.1038/nsmb.2825
Lambrus BG, Holland AJ. A new mode of mitotic surveillance. Trends Cell Biol. 2017;27:314–21.
pubmed: 28188027 pmcid: 5403546 doi: 10.1016/j.tcb.2017.01.004
Paysan L, Piquet L, Saltel F, Moreau V. Rnd3 in cancer: a review of the evidence for tumor promoter or suppressor. Mol Cancer Res. 2016;14:1033–44.
pubmed: 27555595 doi: 10.1158/1541-7786.MCR-16-0164
Hamann JC, Surcel A, Chen R, Teragawa C, Albeck JG, Robinson DN, et al. Entosis is induced by glucose starvation. Cell Rep. 2017;20:201–10.
pubmed: 28683313 pmcid: 5559205 doi: 10.1016/j.celrep.2017.06.037
Banko MR, Allen JJ, Schaffer BE, Wilker EW, Tsou P, White JL, et al. Chemical genetic screen for AMPKalpha2 substrates uncovers a network of proteins involved in mitosis. Mol Cell. 2011;44:878–92.
pubmed: 22137581 pmcid: 3246132 doi: 10.1016/j.molcel.2011.11.005
Li Z, Zhang X. Kinases involved in both autophagy and mitosis. Int J Mol Sci. 2017;18:1884.
pmcid: 5618533 doi: 10.3390/ijms18091884
Wan Q, Liu J, Zheng Z, Zhu H, Chu X, Dong Z, et al. Regulation of myosin activation during cell-cell contact formation by Par3-Lgl antagonism: entosis without matrix detachment. Mol Biol Cell. 2012;23:2076–91.
pubmed: 22496418 pmcid: 3364173 doi: 10.1091/mbc.e11-11-0940

Auteurs

Jianqing Liang (J)

Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China.
State Key Laboratory of Genetic Engineering, School of Life Science, Fudan University, 2005 Songhu Road, Shanghai, 200438, China.

Zubiao Niu (Z)

Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China.

Bo Zhang (B)

Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China.
Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, 10 TIEYI Road, Beijing, 100038, China.

Xiaochen Yu (X)

Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China.

You Zheng (Y)

Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China.

Chenxi Wang (C)

Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China.

He Ren (H)

Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China.
Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, 10 TIEYI Road, Beijing, 100038, China.

Manna Wang (M)

Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China.
Institute of Molecular Immunology, Southern Medical University, Guangzhou, 510515, China.

Banzhan Ruan (B)

Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China.

Hongquan Qin (H)

Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China.
Institute of Molecular Immunology, Southern Medical University, Guangzhou, 510515, China.

Xin Zhang (X)

Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China.
Department of Pediatric Hematology and Oncology, Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China.

Songzhi Gu (S)

Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China.

Xiaoyong Sai (X)

National Clinic Center of Geriatric & the State Key Laboratory of Kidney, the Chinese PLA General Hospital, Beijing, 100853, China.

Yanhong Tai (Y)

The 307 Hospital, 8 Dongda Street, Beijing, 100071, China.

Lihua Gao (L)

Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China.

Li Ma (L)

Institute of Molecular Immunology, Southern Medical University, Guangzhou, 510515, China.

Zhaolie Chen (Z)

Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China.

Hongyan Huang (H)

Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, 10 TIEYI Road, Beijing, 100038, China. hhongy1999@126.com.

Xiaoning Wang (X)

National Clinic Center of Geriatric & the State Key Laboratory of Kidney, the Chinese PLA General Hospital, Beijing, 100853, China. xnwang88@163.com.

Qiang Sun (Q)

Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China. sunq@bmi.ac.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH